Literature DB >> 9470155

Signalment, survival, and prognostic factors in Doberman pinschers with end-stage cardiomyopathy.

C A Calvert1, C W Pickus, G J Jacobs, J Brown.   

Abstract

Congestive heart failure (CHF) was evaluated by retrospective review of case records of 66 Doberman Pinschers presenting with overt signs of 2 weeks' duration or less. Left-sided CHF was predominant, the majority of dogs were male, most were 5 to 10 years of age, and CHF tended to occur in females at an older age. Sudden death occurred in 13 dogs (20%). The mean and median survival times of all dogs were 9.65 and 6.5 weeks, respectively. Both atrial fibrillation and bilateral CHF at the time of presentation were associated with significantly shorter survival times.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9470155     DOI: 10.1111/j.1939-1676.1997.tb00474.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  12 in total

1.  A missense variant in the titin gene in Doberman pinscher dogs with familial dilated cardiomyopathy and sudden cardiac death.

Authors:  Kathryn M Meurs; Steven G Friedenberg; Justin Kolb; Chandra Saripalli; Paola Tonino; Kathleen Woodruff; Natasha J Olby; Bruce W Keene; Darcy B Adin; Oriana L Yost; Teresa C DeFrancesco; Sunshine Lahmers; Sandra Tou; G Diane Shelton; Henk Granzier
Journal:  Hum Genet       Date:  2019-02-04       Impact factor: 4.132

Review 2.  Genetic Basis of Dilated Cardiomyopathy in Dogs and Its Potential as a Bidirectional Model.

Authors:  Karen R Gaar-Humphreys; Talitha C F Spanjersberg; Giorgia Santarelli; Guy C M Grinwis; Viktor Szatmári; Bernard A J Roelen; Aryan Vink; J Peter van Tintelen; Folkert W Asselbergs; Hille Fieten; Magdalena Harakalova; Frank G van Steenbeek
Journal:  Animals (Basel)       Date:  2022-06-29       Impact factor: 3.231

3.  A predictive model for canine dilated cardiomyopathy-a meta-analysis of Doberman Pinscher data.

Authors:  Siobhan Simpson; Jennifer Edwards; Richard D Emes; Malcolm A Cobb; Nigel P Mongan; Catrin S Rutland
Journal:  PeerJ       Date:  2015-03-26       Impact factor: 2.984

4.  Relation of vitamin D status to congestive heart failure and cardiovascular events in dogs.

Authors:  M S Kraus; K M Rassnick; J J Wakshlag; A R M Gelzer; A S Waxman; A M Struble; K Refsal
Journal:  J Vet Intern Med       Date:  2013-11-07       Impact factor: 3.333

5.  Predictors of Sudden Cardiac Death in Doberman Pinschers with Dilated Cardiomyopathy.

Authors:  L Klüser; P J Holler; J Simak; G Tater; P Smets; D Rügamer; H Küchenhoff; G Wess
Journal:  J Vet Intern Med       Date:  2016-05       Impact factor: 3.333

6.  Multiple Genetic Associations with Irish Wolfhound Dilated Cardiomyopathy.

Authors:  Siobhan Simpson; Mark D Dunning; Serena Brownlie; Janika Patel; Megan Godden; Malcolm Cobb; Nigel P Mongan; Catrin S Rutland
Journal:  Biomed Res Int       Date:  2016-12-13       Impact factor: 3.411

7.  Retrospective Evaluation of the Effect of Heart Rate on Survival in Dogs with Atrial Fibrillation.

Authors:  B Pedro; J Dukes-McEwan; M A Oyama; M S Kraus; A R Gelzer
Journal:  J Vet Intern Med       Date:  2017-12-04       Impact factor: 3.333

8.  Detection and comparison of microRNA expression in the serum of Doberman Pinschers with dilated cardiomyopathy and healthy controls.

Authors:  Carola Steudemann; Stefan Bauersachs; Karin Weber; Gerhard Wess
Journal:  BMC Vet Res       Date:  2013-01-17       Impact factor: 2.741

Review 9.  Genetics of Human and Canine Dilated Cardiomyopathy.

Authors:  Siobhan Simpson; Jennifer Edwards; Thomas F N Ferguson-Mignan; Malcolm Cobb; Nigel P Mongan; Catrin S Rutland
Journal:  Int J Genomics       Date:  2015-07-22       Impact factor: 2.326

10.  Occurrence of cardiorespiratory diseases and impact on lifespan in Swedish Irish Wolfhounds: a retrospective questionnaire-based study.

Authors:  Lovisa Orleifson; Ingrid Ljungvall; Katja Höglund; Jens Häggström
Journal:  Acta Vet Scand       Date:  2017-08-02       Impact factor: 1.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.